Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Femal
This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).
| Condition(s) | Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV). |
| Who can participate | Inclusion Criteria: * \* Female patients with diagnosed HPV(+)OPSCC seen at the Mayo Clinic, Rochester * Age ≥ 18 * Female partners of Mayo Clinic patients with diagnosed HPV(+)OPSCC * Patient has given permission to give his/her blood/saliva sample for research testing * Ability to complete questionnaire(s) by themselves or with assistance Exclusion Criteria: * \* HPV(-) OPSCC * Unable to provide informed consent * Unwilling to attend screening visit at Mayo Clinic site, if indicated * Unwilling/unable to complete surveys electronically |
| Ages | 18 Years |
| Sex | Female |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Mayo Clinic |
| Locations | Rochester, Minnesota, United States |
| Start date | 2022-11-01 |
| NCT ID | NCT06115772 |
| Official listing | https://clinicaltrials.gov/study/NCT06115772 |